PD.02.03 Alterations in the Immune Profile of LUSC and LUAD Detected by a Neural Network May Reveal New Immunotherapy Targets
Journal of Thoracic Oncology(2023)
Abstract
Although immune checkpoint inhibitors (ICI) provided unprecedented survival improvement for patients with advanced non-small cell lung cancer (NSCLC), their benefit in NSCLC is limited to a subset of patients. Characterization of the complex and heterogeneous tumor microenvironment (TME) in NSCLC, particularly between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), is essential to reveal promising targets.
MoreTranslated text
Key words
immune profile,luad,immunotherapy,lusc
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined